Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of hub genes and transcription factors in patients with rheumatoid arthritis complicated with atherosclerosis. | Sci Rep | 2022 | 35304503 | PubTator, text mining | PubMed |
| Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management. | Clin Rev Allergy Immunol | 2022 | 35303257 | PubTator, text mining | PubMed |
| Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm. | PLoS One | 2022 | 35303006 | PubTator, text mining | PubMed |
| Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. | Elife | 2022 | 35302493 | PubTator, text mining | PubMed |
| The Molecular Mechanism of Aerobic Exercise Improving Vascular Remodeling in Hypertension. | Front Physiol | 2022 | 35295586 | PubTator, text mining | PubMed |
| Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs. | Exp Physiol | 2022 | 35293040 | PubTator, text mining | PubMed |
| Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants. | Dis Model Mech | 2022 | 35284927 | PubTator, text mining | PubMed |
| Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma. | Ann Transl Med | 2022 | 35280360 | PubTator, text mining | PubMed |
| Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders. | Int J Mol Sci | 2022 | 35269741 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies. | Int J Mol Sci | 2022 | 35269636 | PubTator, text mining | PubMed |
| Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1. | Theranostics | 2022 | 35265193 | PubTator, text mining | PubMed |
| A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma. | Front Genet | 2022 | 35251120 | PubTator, text mining | PubMed |
| The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation. | Front Immunol | 2022 | 35250981 | PubTator, text mining | PubMed |
| Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer. | Front Physiol | 2022 | 35250621 | PubTator, text mining | PubMed |
| Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study. | Lancet HIV | 2022 | 35245508 | PubTator, text mining | PubMed |
| Mechanistic study of the effect of Endothelin SNPs in microvascular angina - Protocol of the PRIZE Endothelin Sub-Study. | Int J Cardiol Heart Vasc | 2022 | 35242999 | PubTator, text mining | PubMed |
| Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies. | Cureus | 2022 | 35242466 | PubTator, text mining | PubMed |
| SINAPs: A Software Tool for Analysis and Visualization of Interaction Networks of Molecular Dynamics Simulations. | J Chem Inf Model | 2022 | 35239339 | PubTator, text mining | PubMed |
| The Involvement of Endothelin Pathway in Chronic Psychological Stress-Induced Bladder Hyperalgesia Through Capsaicin-Sensitive C-Fiber Afferents. | J Inflamm Res | 2022 | 35228812 | PubTator, text mining | PubMed |
| Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation via the Inhibition of ILC2 Function. | Front Immunol | 2022 | 35222426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=41